The oral PI3Kdelta inhibitor Linperlisib and Obinutuzumab as response-dependent, first-line regimen for marginal zone lymphoma: A prospective single-arm Phase Ib/II Study
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Jia Li, Xingtong Wang, Wei Guo, Yangzhi Zhao, chunshui liu, Ou Bai
Institution: First Hospital of Jilin University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417002673
Cites:
Cited by:
Related to: